Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

G. Bertelli; R. Trovato; S. Ugel; Emilio Bria; M. Milella; V. Bronte; S. Pilotto

doi:10.1016/j.cllc.2019.04.013

Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

G. Bertelli
, R. Trovato
, S. Ugel^*
, Emilio Bria
, M. Milella
, V. Bronte
, S. Pilotto

^*Autore corrispondente per questo lavoro

Ospedale Policlinico

Risultato della ricerca: Contributo in rivista › Articolo

3 Citazioni (Scopus)

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	e514-e516
Numero di pagine	3
Rivista	Clinical Lung Cancer
Volume	20
Numero di pubblicazione	4
DOI	https://doi.org/10.1016/j.cllc.2019.04.013
Stato di pubblicazione	Pubblicato - 2019

All Science Journal Classification (ASJC) codes

Oncologia
Medicina Polmonare e Respiratoria
Ricerca sul Cancro

Keywords

Immunotherapy
MDSC
NSCLC
Predictive biomarkers
Tumor-induced immunosuppression

Accesso al documento

10.1016/j.cllc.2019.04.013

Altri file e collegamenti

Cita questo

@article{0ada3294616a4addb934570719e87092,

title = "Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report",

abstract = "N/A",

keywords = "Immunotherapy, MDSC, NSCLC, Predictive biomarkers, Tumor-induced immunosuppression, Immunotherapy, MDSC, NSCLC, Predictive biomarkers, Tumor-induced immunosuppression",

author = "G. Bertelli and R. Trovato and S. Ugel and Emilio Bria and M. Milella and V. Bronte and S. Pilotto",

year = "2019",

doi = "10.1016/j.cllc.2019.04.013",

language = "English",

volume = "20",

pages = "e514--e516",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

AU - Bertelli, G.

AU - Trovato, R.

AU - Ugel, S.

AU - Bria, Emilio

AU - Milella, M.

AU - Bronte, V.

AU - Pilotto, S.

PY - 2019

Y1 - 2019

N2 - N/A

AB - N/A

KW - Immunotherapy

KW - MDSC

KW - NSCLC

KW - Predictive biomarkers

KW - Tumor-induced immunosuppression

KW - Immunotherapy

KW - MDSC

KW - NSCLC

KW - Predictive biomarkers

KW - Tumor-induced immunosuppression

UR - https://publicatt.unicatt.it/handle/10807/139997

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85065830595&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065830595&origin=inward

U2 - 10.1016/j.cllc.2019.04.013

DO - 10.1016/j.cllc.2019.04.013

M3 - Article

SN - 1525-7304

VL - 20

SP - e514-e516

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 4

ER -

Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo